✦ LIBER ✦

Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (A Gynecologic Oncology Group Study)

✍ Scribed by Gregory P. Sutton; Brian N. Bundy; George A. Omura; Edgardo L. Yordan; Jackson B. Beecham; Thomas Bonfiglio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stage III ovarian tumors of low malignan

✍ G. Sutton; B. Bundy; G. Omura; E. Yordan; J. Beecham 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Bleomycin, Etoposide, and Cisplatin Comb

✍ Howard D. Homesley; Brian N. Bundy; Jean A. Hurteau; Lawrence M. Roth 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Prognostic factors for stage III epithel

✍ L. Landrum; J. Java; C. Mathews; G. Lanneau; L. Copeland; D. Armstrong; J. Walke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Prognostic factors for stage III epithel

✍ Landrum, Lisa M.; Java, James; Mathews, Cara A.; Lanneau, Grainger S.; Copeland, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Cisplatin as second-line therapy in ovar

✍ J.Tate Thigpen; John A Blessing; George Olt; Samuel S Lentz; Jeffrey Bell 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Effect of surgical staging on 539 patien

✍ Guvenal, Tevfik; Dursun, Polat; Hasdemir, Pinar S.; Hanhan, Merih; Guven, Suleym 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 304 KB